scholarly journals European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management

2018 ◽  
Vol 22 (9) ◽  
pp. 1547-1564 ◽  
Author(s):  
Winfried Häuser ◽  
David P. Finn ◽  
Eija Kalso ◽  
Nevenka Krcevski-Skvarc ◽  
Hans-Georg Kress ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Pain Management ◽  
Position Paper ◽  
Chronic Pain Management ◽  
Medical Cannabis ◽  
Appropriate Use

Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management

2019 ◽  
Vol 15 (2) ◽  
pp. 147-158 ◽  
Author(s):  
Tony O’Brien, MB, FRCPI ◽  
Jin Seok Ahn, MD ◽  
Richard Chye, MBBS, FRACP, FFPMANZCA, FAChPM ◽  
Brian Le, MBBS (Hons), MPH, FRACP, FAChPM ◽  
Henry Lu, MD, DABPN, DPBPM ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Neuropathic Pain ◽  
Pain Management ◽  
Cancer Pain ◽  
Chronic Pain Management ◽  
Cancer Pain Management ◽  
Appropriate Use ◽  
Chronic Pain Conditions ◽  
Favorable Safety ◽  
Practical Recommendations

Transdermal buprenorphine (TDB) has demonstrated effectiveness in treating a range of chronic pain conditions, including cancer pain, nociceptive pain, and neuropathic pain and has a favorable safety profile. Worldwide, clinical experience of its use is relatively limited. There is considerable misunderstanding about the pharmacology, mechanism of action, and safety of buprenorphine. There is also limited guidance on the appropriate use of TDB for chronic pain management. This article presents an overview of TDB and also provides practical recommendations for its use as part of a multifaceted strategy in chronic cancer and non-cancer pain.

scholarly journals European Pain Federation position paper on appropriate opioid use in chronic pain management

2016 ◽  
Vol 21 (1) ◽  
pp. 3-19 ◽  
Author(s):  
T. O'Brien ◽  
L.L. Christrup ◽  
A.M. Drewes ◽  
M.T. Fallon ◽  
H.G. Kress ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Pain Management ◽  
Position Paper ◽  
Chronic Pain Management ◽  
Opioid Use

scholarly journals Long-Acting Opioids and Short-Acting Opioids: Appropriate Use in Chronic Pain Management

Pain Medicine ◽  
2009 ◽  
Vol 10 (suppl 2) ◽  
pp. S79-S88 ◽  
Author(s):  
Perry G. Fine ◽  
Gagan Mahajan ◽  
Mary Lynn McPherson
Keyword(s):  
Chronic Pain ◽  
Pain Management ◽  
Chronic Pain Management ◽  
Appropriate Use ◽  
Short Acting ◽  
Long Acting

scholarly journals Framing of the opioid problem in cancer pain management in Canada

2019 ◽  
Vol 26 (3) ◽  
Author(s):  
R. Asthana ◽  
S. Goodall ◽  
J. Lau ◽  
C. Zimmermann ◽  
P. L. Diaz ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Pain Management ◽  
Cancer Pain ◽  
Opioid Therapy ◽  
Position Paper ◽  
Chronic Pain Management ◽  
Opioid Use ◽  
Cancer Pain Management ◽  
Canadian Guideline ◽  
Patients With Cancer

Two guidelines about opioid use in chronic pain management were published in 2017: the Canadian Guideline for Opioids for Chronic Non-Cancer Pain and the European Pain Federation position paper on appropriate opioid use in chronic pain management. Though the target populations for the guidelines are the same, their recommendations differ depending on their purpose. The intent of the Canadian guideline is to reduce the incidence of serious adverse effects. Its goal was therefore to set limits on the use of opioids. In contrast, the European Pain Federation position paper is meant to promote safe and appropriate opioid use for chronic pain.     The content of the two guidelines could have unintentional consequences on other populations that receive opioid therapy for symptom management, such as patients with cancer. In this article, we present expert opinion about those chronic pain management guidelines and their impact on patients with cancer diagnoses, especially those with histories of substance use disorder and psychiatric conditions. Though some principles of chronic pain management can be extrapolated, we recommend that guidelines for cancer pain management should be developed using empirical data primarily from patients with cancer who are receiving opioid therapy.

Sign in / Sign up

Export Citation Format

Share Document